These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 18508458

  • 1. Tremorolytic effects of adenosine A2A antagonists: implications for parkinsonism.
    Salamone JD, Betz AJ, Ishiwari K, Felsted J, Madson L, Mirante B, Clark K, Font L, Korbey S, Sager TN, Hockemeyer J, Muller CE.
    Front Biosci; 2008 May 01; 13():3594-605. PubMed ID: 18508458
    [Abstract] [Full Text] [Related]

  • 2. Effects of the adenosine A 2A antagonist KW 6002 (istradefylline) on pimozide-induced oral tremor and striatal c-Fos expression: comparisons with the muscarinic antagonist tropicamide.
    Betz AJ, Vontell R, Valenta J, Worden L, Sink KS, Font L, Correa M, Sager TN, Salamone JD.
    Neuroscience; 2009 Sep 29; 163(1):97-108. PubMed ID: 19467297
    [Abstract] [Full Text] [Related]

  • 3. The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
    Correa M, Wisniecki A, Betz A, Dobson DR, O'Neill MF, O'Neill MJ, Salamone JD.
    Behav Brain Res; 2004 Jan 05; 148(1-2):47-54. PubMed ID: 14684247
    [Abstract] [Full Text] [Related]

  • 4. Deep brain stimulation of the subthalamic nucleus reverses oral tremor in pharmacological models of parkinsonism: interaction with the effects of adenosine A2A antagonism.
    Collins-Praino LE, Paul NE, Ledgard F, Podurgiel SJ, Kovner R, Baqi Y, Müller CE, Senatus PB, Salamone JD.
    Eur J Neurosci; 2013 Jul 05; 38(1):2183-91. PubMed ID: 23600953
    [Abstract] [Full Text] [Related]

  • 5. Oral tremor induced by the muscarinic agonist pilocarpine is suppressed by the adenosine A2A antagonists MSX-3 and SCH58261, but not the adenosine A1 antagonist DPCPX.
    Collins LE, Galtieri DJ, Brennum LT, Sager TN, Hockemeyer J, Müller CE, Hinman JR, Chrobak JJ, Salamone JD.
    Pharmacol Biochem Behav; 2010 Feb 05; 94(4):561-9. PubMed ID: 19958787
    [Abstract] [Full Text] [Related]

  • 6. The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor.
    Podurgiel SJ, Nunes EJ, Yohn SE, Barber J, Thompson A, Milligan M, Lee CA, López-Cruz L, Pardo M, Valverde O, Lendent C, Baqi Y, Müller CE, Correa M, Salamone JD.
    Neuroscience; 2013 Oct 10; 250():507-19. PubMed ID: 23867769
    [Abstract] [Full Text] [Related]

  • 7. Induction of oral tremor in mice by the acetylcholinesterase inhibitor galantamine: Reversal with adenosine A2A antagonism.
    Podurgiel SJ, Spencer T, Kovner R, Baqi Y, Müller CE, Correa M, Salamone JD.
    Pharmacol Biochem Behav; 2016 Jan 10; 140():62-7. PubMed ID: 26459156
    [Abstract] [Full Text] [Related]

  • 8. Blockade of adenosine A2A receptors inhibits Tremulous Jaw Movements as well as expression of zif-268 and GAD65 mRNAs in brain motor structures.
    Kosmowska B, Ossowska K, Wardas J.
    Behav Brain Res; 2022 Jan 24; 417():113585. PubMed ID: 34536428
    [Abstract] [Full Text] [Related]

  • 9. Conditional neural knockout of the adenosine A(2A) receptor and pharmacological A(2A) antagonism reduce pilocarpine-induced tremulous jaw movements: studies with a mouse model of parkinsonian tremor.
    Salamone JD, Collins-Praino LE, Pardo M, Podurgiel SJ, Baqi Y, Müller CE, Schwarzschild MA, Correa M.
    Eur Neuropsychopharmacol; 2013 Aug 24; 23(8):972-7. PubMed ID: 22947264
    [Abstract] [Full Text] [Related]

  • 10. The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.
    Collins LE, Sager TN, Sams AG, Pennarola A, Port RG, Shahriari M, Salamone JD.
    Pharmacol Biochem Behav; 2012 Jan 24; 100(3):498-505. PubMed ID: 22037410
    [Abstract] [Full Text] [Related]

  • 11. Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism.
    Salamone JD, Ishiwari K, Betz AJ, Farrar AM, Mingote SM, Font L, Hockemeyer J, Müller CE, Correa M.
    Parkinsonism Relat Disord; 2008 Jan 24; 14 Suppl 2(Suppl 2):S130-4. PubMed ID: 18585081
    [Abstract] [Full Text] [Related]

  • 12. Tremorolytic effects of safinamide in animal models of drug-induced parkinsonian tremor.
    Podurgiel S, Collins-Praino LE, Yohn S, Randall PA, Roach A, Lobianco C, Salamone JD.
    Pharmacol Biochem Behav; 2013 Apr 24; 105():105-11. PubMed ID: 23360954
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Validation of the tremulous jaw movement model for assessment of the motor effects of typical and atypical antipychotics: effects of pimozide (Orap) in rats.
    Ishiwari K, Betz A, Weber S, Felsted J, Salamone JD.
    Pharmacol Biochem Behav; 2005 Feb 24; 80(2):351-62. PubMed ID: 15680188
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of adenosine A2A receptor antagonists on haloperidol-induced movement disorders in primates.
    Varty GB, Hodgson RA, Pond AJ, Grzelak ME, Parker EM, Hunter JC.
    Psychopharmacology (Berl); 2008 Oct 24; 200(3):393-401. PubMed ID: 18594798
    [Abstract] [Full Text] [Related]

  • 19. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
    Betz AJ, McLaughlin PJ, Burgos M, Weber SM, Salamone JD.
    Psychopharmacology (Berl); 2007 Oct 24; 194(3):347-59. PubMed ID: 17594079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.